A vaccine is a biological mix that makes the body more resistant to diseases. Vaccine production is getting better, with cutting-edge technologies that can deal with both new and old strains of viruses.
With the spread of the SARS-CoV-2 virus, technology has moved quickly and there has been more interest than ever in making vaccines.
Synergy Bioscience has the scientific knowledge, state-of-the-art equipment, and strong industry knowledge to make vaccines to fight new diseases and pathogens around the world that traditional vaccine technologies haven’t been able to stop.
We have scientists who are experts in drug delivery and synthesis, and they use the latest artificial intelligence (AI) technologies to help science. AI is a promising tool we can use to speed up the development of vaccines and drugs, which saves a lot of money compared to the old ways of doing things. Because of these improvements, we can back a rise in the number of successful market approvals (MAs).
By working with us, you’ll get a service that is enriching, easy to use, and of the highest quality. You will see a big drop in the cost of investments you need to make, and your business will be more stable and your vaccine development pipelines will be more flexible.
We could make subunit vaccines like virus-like particles (VLP) and nanoparticles more effective. Subunit vaccines make antigens in the form of purified protein, which shows that they are safer and can be used on a larger scale than pathogen vaccines.